DGX - Quest Diagnostics Incorporated
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$250.00
DETAILS
HIGH:
$260.00
LOW:
$225.00
MEDIAN:
$255.00
CONSENSUS:
$250.00
UPSIDE:
8.43%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Greenblatt | 117,533 | $24.9M | 0.1% | -13,244 | DECREASED |
| Wood | 23,380 | $5.0M | 0.0% | +23,380 | INCREASED |
| Cooperman | 4,814 | $1.0M | 0.0% | -142,913 | DECREASED |
| Dalio | 3,756 | $796,084 | 0.0% | +285 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-10-01 | WENTWORTH TIMOTHY C | director | A-Award | 135 | -- | -- |
| 2026-09-01 | Davis J. E. | director, officer: CEO and President | SELL | 10,000 | $242.72 | $2.4M |
| 2026-08-28 | PREVOZNIK MICHAEL E | officer: SVP & General Counsel | SELL | 6,237 | $243.63 | $1.5M |
| 2026-08-28 | PREVOZNIK MICHAEL E | officer: SVP & General Counsel | SELL | 430 | $244.51 | $105K |
| 2026-08-28 | PREVOZNIK MICHAEL E | officer: SVP & General Counsel | G-Gift | 1,000 | -- | -- |
| 2026-08-28 | PREVOZNIK MICHAEL E | officer: SVP & General Counsel | SELL | 16,010 | $242.88 | $3.9M |
| 2026-08-28 | PREVOZNIK MICHAEL E | officer: SVP & General Counsel | M-Exempt | 22,677 | $112.17 | $2.5M |
| 2026-07-28 | DELANEY MARK E | officer: SVP & Chief Commercial Officer | SELL | 1,600 | $235.18 | $376K |
| 2026-07-22 | Lassiter Wright III | director | L-Small | 6 | $206.81 | $1K |
| 2026-07-22 | CARTER ROBERT B | director | L-Small | 11 | $206.80 | $2K |
| 2026-07-22 | Plewman Patrick | officer: SVP for Diagnostic Services | L-Small | 46 | $206.81 | $10K |
| 2026-07-22 | KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | L-Small | 37 | $206.81 | $8K |
| 2026-07-22 | MAIN TIMOTHY L | director | L-Small | 21 | $206.81 | $4K |
| 2026-07-22 | SAMAD SAM | officer: Executive Vice President & CFO | A-Award | 102 | $206.81 | $21K |
| 2026-07-22 | DELANEY MARK E | officer: SVP & Chief Commercial Officer | L-Small | 34 | $206.81 | $7K |
| 2026-07-22 | Gregg Vicky B | director | A-Award | 72 | $206.81 | $15K |
| 2026-07-01 | WENTWORTH TIMOTHY C | director | A-Award | 144 | -- | -- |
| 2026-06-04 | KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | SELL | 8,147 | $200.00 | $1.6M |
| 2026-06-04 | KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | M-Exempt | 4,827 | $121.81 | $588K |
| 2026-06-04 | KUPPUSAMY KARTHIK | officer: SVP, Clinical Solutions | M-Exempt | 3,320 | $127.72 | $424K |
| 2026-06-01 | Davis J. E. | director, officer: CEO and President | SELL | 10,000 | $194.14 | $1.9M |
| 2026-05-20 | MORRISON DENISE M | director | A-Award | 1,142 | -- | -- |
| 2026-05-20 | Gregg Vicky B | director | A-Award | 1,142 | -- | -- |
| 2026-05-20 | CARTER ROBERT B | director | A-Award | 1,142 | -- | -- |
| 2026-05-20 | MAIN TIMOTHY L | director | A-Award | 1,142 | -- | -- |
Congressional Trading
| DATE | MEMBER | CHAMBER | TYPE | AMOUNT |
|---|---|---|---|---|
| 2026-08-14 | Carol Devine Miller | HOUSE | Sale | $15,001 - $50,000 |
| 2026-08-06 | Julie Johnson | HOUSE | Purchase | $1,001 - $15,000 |
| 2026-08-06 | Julie Johnson | HOUSE | Sale | $1,001 - $15,000 |
| 2026-07-21 | Alan Armstrong | SENATE | Purchase | $1,001 - $15,000 |